短期住院戒烟治疗与标准门诊团体治疗疗效比较(START研究):随机对照试验研究方案
本研究为随机对照试验,旨在比较短期住院行为治疗戒烟与标准门诊行为治疗团体戒烟的长期疗效。受试者为每日吸烟10支及以上且愿意戒烟的成年吸烟者,按1:1随机分组。主要终点为6个月和12个月持续戒断率,次要终点包括治疗后吸烟状态、7天时点戒断率、躯体依赖程度、成本效果等。
要点
- 首个比较住院戒烟治疗与门诊团体治疗长期疗效的前瞻性随机对照试验。
- 主要终点为6个月和12个月持续戒断率。
- 住院治疗由移动专家团队实施,可推广至无常驻戒烟人员的医疗中心。
核心结论
- 短期住院戒烟治疗可能通过更高环境控制、更密集接触和更强支持提高长期戒断率,但尚待本试验验证。
- 本研究为首个前瞻性随机对照试验,比较住院戒烟治疗与标准门诊团体治疗的长期疗效。
研究设计与样本
- 随机对照试验,将成年吸烟者按1:1随机分配至住院行为治疗戒烟组或标准门诊行为治疗团体戒烟组。
- 纳入标准为每日吸烟10支及以上且愿意戒烟的成年吸烟者。
- 评估时间点为基线、治疗后、戒烟后6个月和12个月。
关键数值与推荐
- 主要终点为6个月和12个月持续戒断率。
- 次要终点包括治疗后吸烟状态、6个月和12个月随访时7天时点戒断率、躯体依赖程度、成本效果、尼古丁替代产品使用、健康相关生活质量、戒烟自我效能期望、行为改变的动机和意志决定因素、自报抑郁症状严重程度、不良事件及可能副作用。
临床怎么用
- 住院治疗模式由移动专家团队实施,可应用于无常驻戒烟人员的医疗中心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Germany, evidence-based outpatient smoking cessation therapies are widely available. Long-term abstinence rates, however, are limited. Studies suggest that short-term residential therapy enables a higher level of environmental control, more intense contact and greater support among patients and from therapists, which could result in higher abstinence rates. The aim of the current START-study is to investigate the long-term efficacy of a short-term residential therapy exclusively for smoking cessation, conducted by a mobile team of expert therapists. METHODS: A randomized controlled trial (RCT) is conducted to examine the efficacy of residential behavior therapeutic smoking cessation therapy compared to standard outpatient behavior therapeutic smoking cessation group therapy. Adult smokers consuming 10 or more cigarettes per day, who are willing to stop smoking, are randomized in a ratio of 1:1 between therapy groups. The primary endpoint is sustained abstinence for 6-month and 12-month periods. Secondary endpoints include smoking status after therapy, 7-day point abstinence after the 6-month and 12-month follow-ups, level of physical dependence, cost-effectiveness, use of nicotine replacement products, health-related quality of life, self-efficacy expectation for tobacco abstinence, motivational and volitional determinants of behavior change, self-reported depressive symptom severity, adverse events and possible side effects. Assessments will take place at baseline, post-therapy, and at 6-month and 12-month intervals after smoking cessation. DISCUSSION: There is a high demand for long-term effective smoking cessation therapies. This study represents the first prospective RCT to examine the long-term efficacy of a residential smoking cessation therapy program compared to standard outpatient group therapy as an active control condition. The residential therapeutic concept may serve as a new model to substantially enhance future cessation therapies and improve the understanding of therapeutic impact factors on tobacco abstinence. Utilizing a mobile team, the model could be applied efficiently to medical centers that do not have permanent and trained personnel for smoking cessation at their disposal. TRIAL REGISTRATION: German Register for Clinical Trials (Deutsches Register für Klinische Studien), DRKS00013466. Retrospectively registered on 1 April 2019. https://www.drks.de/drks_web/navigate.do?navigationId=start.
引用
- Dickreuter J, Schmoor C, Bengel J, et al. Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy ('START-Study'): study protocol of a randomized controlled trial. Trials. 2020. PMID: 32576275. doi:10.1186/s13063-020-04253-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。